We’re a team of clinicians and staff who have dedicated our lives to research, education, and treating those with mental health conditions. We’re especially passionate about helping those with Treatment-Resistant Depression and providing the most advanced therapies available, including Transcranial Magnetic Stimulation (TMS) and esketamine nasal spray, both FDA-approved for advanced depression.
Mental health conditions can be profoundly painful and isolating, making it difficult to seek help. Our team provides a unique, patient-centered experience to help you find the appropriate treatment and relief from your symptoms. We’re grateful to be practicing psychiatry during this era in which there are so many new treatment possibilities and new hope for those with mental health conditions.
Dr. Rama Dronamraju works with her patients as partners in treatment, helping them understand their symptoms, the nature of their illness, and the treatment itself. She sees them as a whole person with a full life, and compassionately works with them to provide knowledge and insight into their struggles and often bringing their families into the fold. She helps them remain in treatment and avoid relapse, providing them with tools to lead meaningful, functional lives.
She has found that for patients with mood disorders, response to standard medication and therapy is often limited. She has treated with Electroconvulsive Therapy for many years and has witnessed her patients find relief and recovery. She looks forward to treating patients with TMS as a treatment modality as it has the potential to benefit various types of patients and is non-invasive, not requiring anesthesia and having few if any side effects.
Rama Dronamraju joined Mindful Health Solutions in the Fall of 2019.
Since high school if not earlier, Dr. Benjamin Cheyette has been analytical about human behavior and interested in the brain. While initially leaning towards academia, he found great satisfaction in direct patient care during medical school and beyond. Throughout his years of research and professorship, he continued to treat patients and is passionate about helping people overcome emotional challenges.
He has a collaborative approach that emphasizes sharing his deep formal expertise and clinical experience to help patients make well-informed decisions. He recognizes that for all patients in the outpatient setting, treatment for mental health is a choice, and so a patient must be on board with any proposed therapeutic approach. He has found the best way to achieve this is by offering a thorough explanation of his thought process, so that his patients understand his rationale for recommending a course of treatment.
Having spent several decades in academia as a research scientist, Dr. Benjamin Cheyette is interested in cutting-edge innovations such as Transcranial Magnetic Stimulation (TMS), the emerging field of psychedelic medicine, and applying these treatments to patient care in an evidence-based manner.
Kimberly Dow is a Psychiatric Mental Health Nurse Practitioner (PMHNP) who provides her expert care at our Burlingame clinic. She practices general psychiatry and is able to help patients with a variety of cases. However, her specialties include working with mood disorders, including anxiety, depression, bipolar disorder, and ADHD. She fell in love with psychiatry after taking her first psychology class in college. She is passionate about understanding her patients on a personal level to find them the best treatment options possible.
Kimberly joined Mindful Health Solutions with an admiration for our evidence-based practices. Also, working in a clinic that is patient-centered was a top priority for her. She wants to have a significantly positive impact on patients through cutting-edge treatments including transcranial magnetic stimulation (TMS) therapy and esketamine nasal spray. Overall, she wants to be a part of an organization that allows providers to spend time getting to know their patients as people.
As a practitioner, Kimberly Dow embraces a collaborative approach with her patients. She wants to provide knowledge and experience so as to empower her patients to make informed decisions about their available treatment options. Her style is grounded in the mind-body connection by blending mindfulness, behaviors, and holistic interventions with medications.
Dr. Matthew Peters, M.D. is a board-certified psychiatrist who focuses on depression, anxiety, and interventional treatments for those who have not found relief with medications. While in college, he worked part-time as a local journalist in the Bay Area. On the job, he met many people on the streets who suffered from severe mental illness. He enjoyed learning their stories, how their minds worked, and wanted to help alleviate their suffering—and so he pivoted from journalism. He graduated college with a bachelor’s degree in psychology and went on to medical school to become a psychiatrist.
When working with patients, Dr. Peters takes a holistic view of the person and the circumstances that have brought them to seek professional assistance. He pursues a collaborative approach that is informed by evidence-based principles, to maximize the chance of success and minimize the potential risks of treatment. Unfortunately, many patients end up misdiagnosed by previous providers and receive treatments that are unhelpful or even potentially harmful. Dr. Peters will work with you, when appropriate, to ensure you have a thorough and accurate evaluation, diagnosis, and treatment plan that is tailored to your needs and preferences.
After making a careful diagnosis, Dr. Matthew Peters provides treatment via medications and brief cognitive-behavioral and supportive psychotherapies; he can also help patients plan their treatment goals and provide advice on what kind of therapist may best suit their specific needs. Dr. Peters also specializes in treating patients with depression who have not found relief after trying multiple medications. For these patients, he uses new approaches such as Transcranial Magnetic Stimulation (TMS) therapy and esketamine.